Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
4-HO-DPT
Experience:~150mg MDA(oral) - a case of mistaken identity
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
3C-E
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Amanita muscaria
MiPLA
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Experience:337mg DMT fumarate - A Day With DMT
Efavirenz
DOI
4-FA
4-HO-MiPT
GABAergic hallucinogens
2C-T-7
5-MeO-DiPT
TMA-2
ΑMT
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
Omberacetam
Experience:4-AcO-DMT + 200mg Pill
4-AcO-MiPT
MDA
2C-I
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
2C-T-2
Experience:1000 Morning Glory seeds - Rediscovering the Self
Paradise island by Xanny.jpgParadise island by Subsentience
Selective serotonin reuptake inhibitor
Experience:1mg 25c-NBOMe - Experiment in my room
4-HO-MET
25I-NBOH
DOB
DiPT
2C-B-FLY
5-Hydroxytryptophan
Pramiracetam
25I-NBOMe
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Experience:4x 200ug tabs - You do not need to understand
Experience:1050 µg 1cP-LSD - The matrix
Escaline
Experience:25mg 3-MeO-PCP - Enhanced film experience
DPT
EPT
2C-C
2C-B
Chameleon.jpgChameleon by Anonymous.
5-MeO-MiPT
Experience:800 seeds LSA - My First Trip Ever
Aniracetam
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
5-MeO-DALT
1P-ETH-LAD
Ayahuasca
DMT
6-APB
MET
TMA-6
Coluracetam
1P-LSD
DOM
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
25D-NBOMe
MiPT
4-HO-MPT
Allylescaline
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
Experience:120mg - Garden of The Gods
4-HO-DiPT
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Pregabalin
Experience:2 tabs DOB - My DOB Nightmare
MDEA
MDMA
ETH-LAD
Βk-2C-B
4-HO-DET
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Ibogaine
Oxiracetam
Phenylpiracetam
Psilocybin mushrooms
ALD-52
Tree.jpgJapanese Garden by Anonymous
Phenethylamine (compound)
5F-PB-22
LSD
Experience:250mg DXM - DXM Itch and Trip Report
25B-NBOMe
Bromo-DragonFLY
3-MeO-PCE
4-AcO-DiPT
Experience:3-MeO-PCP - Extreme psychosis
LSM-775
Experience:BK-2C-B - Various experiences
PARGY-LAD
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Experience:4-HO-MiPT / A care free psychedelic getaway
4-AcO-DMT
2C-H
MDAI
Proscaline
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
25C-NBOMe
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
4-HO-EPT
LSZ
Experience:300µg LSD - Togetherness and the Silent Dusk
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
DOC
Methallylescaline
Psilocin
25C-NBOH
Experience:4.5g - The Grand Introduction to Beauty and Fear
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
4-AcO-DET
3-MMC
1B-LSD
5-MeO-DiBF
DET
2C-D
AL-LAD
6-APDB
THJ-018
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
4-AcO-MET
MPT
Mescaline
2C-T-21
25B-NBOH
THJ-2201
Piracetam
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
PRO-LAD
2C-E
Experience:25mg Deschloroketamine - My first time orally dosing DCK
JWH-018
Bufotenin
LSA
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Experience:40mg - Brothermind and the Forest's Hand
Memantine
Enhancement of colour rose.jpgRose by Chelsea Morgan
JWH-073
2C-P
25N-NBOMe

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.